October 2017 Vol XLI Issue 10
FRONTIERS IN ENDOSCOPY, SERIES #39
Prognostic Biomarkers in Pancreatic Ductal AdenocarcinomaPancreatic ductal adenocarcinoma (PDAC) carries significant morbidity and mortality and remains one of the most difficult malignancies to treat. Individual patient and tumor factors need to be taken into account to provide an optimal, personalized approach. In this review, we highlight established and novel biomarkers that have the potential to be used as prognostic biomarkers in PDAC and some that may be used to guide therapeutic decisions. We briefly review some blood based biomarkers but focus on those that are tissue based and may be identified and characterized in pancreatic cancer biopsies.
A SPECIAL ARTICLE
A Practical Approach to Managing Inpatient Acute Severe Ulcerative ColitisHospitalized acute severe ulcerative colitis patients require a multidisciplinary team approach with a focus on early escalation of medical therapy and early surgical consultation. This review aims to provide a practical approach on the treatment of inpatient acute severe ulcerative colitis.
NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #168
Nutritional Approaches to Chronic Nausea and VomitingIn addition to a relative lack of definitive diagnostics and effective therapies, maintenance of adequate nutritional intake can represent a significant challenge for patients with chronic nausea and vomiting. This brief review will consider the existing evidence basis for nutritional approaches to a variety of non-structural causes of chronic nausea and/or vomiting, including gastroparesis, chronic nausea and vomiting syndrome, functional dyspepsia, cyclic vomiting syndrome, and rumination syndrome.
A CASE REPORT
A Rare Finding of Colonic MalakoplakiaDepartments Section
GLOBAL, PEER-REVIEWED MEDICAL JOURNAL PUBLISHES RESULTS OF A FIRST-EVER DATA ANALYSIS IN IRRITABLE BOWEL SYNDROME (IBS) PATIENTS WITH MIXED DIARRHEA AND CONSTIPATION (IBS-M), DEMONSTRATING EFFECTIVENESS OF THE NOVEL DELIVERY SYSTEM OF PEPPERMINT OIL IN IBgard®
Washington, D.C. and Boca Raton, FL - IM HealthScience® announced that Internal Medicine Review, a global, peer-reviewed medical journal, has published the first-ever clinical data analysis on the favorable effects of IBgard® specifically among Irritable Bowel Syndrome (IBS) patients with mixed diarrhea and constipation (IBS-M).
NEW SURVEY RANKS DIARRHEA AS NUMBER ONE GASTROINTESTINAL COMPLAINT OF HIV/AIDS PATIENTS
San Francisco, CA - Napo Pharmaceuticals, Inc. (Napo) announced the results of a survey of 271 U.S. board certified gastroenterologists, which indicate that the number one gastrointestinal (GI) complaint for people living with HIV/AIDS is diarrhea.
November 9-11, 2017 - Advances in Inflammatory Bowel Diseases - Multidisciplinary Approaches to IBD Patient - Centered Care New Presenters, New Content, A New Year
Jan. 18-20, 2018 - The Crohn's & Colitis Congress
February 11-14, 2018 - The 2nd Annual The GUILD Conference 2018
June 2-5, 2018 - Digestive Disease Week (DDW)
